Literature DB >> 32204401

Anti-Cancer Potential of Two Plasma-Activated Liquids: Implication of Long-Lived Reactive Oxygen and Nitrogen Species.

Elena Griseti1,2, Nofel Merbahi2, Muriel Golzio1.   

Abstract

Cold atmospheric plasma-exposed culture medium may efficiently kill cancer cells in vitro. Due to the complexity of the medium obtained after plasma exposure, less complex physiological liquids, such as saline solutions and saline buffers, are gathering momentum. Among the plethora of reactive oxygen and nitrogen species (RONS) that are produced in these plasma-activated liquids, hydrogen peroxide, nitrite and nitrate appear to be mainly responsible for cytotoxic and genotoxic effects. Here, we evaluated the anti-cancer potential of plasma-activated phosphate-buffered saline (P-A PBS) and sodium chloride 0.9% (P-A NaCl), using a three-dimensional tumor model. Two epithelial cancer cell lines were used to evaluate cellular effects of either P-A PBS or P-A NaCl. Human colorectal cancer cells HCT 116 and human ovarian carcinoma, SKOV-3 were used to investigate the manner by which different cell types respond to different plasma-activated liquids treatments. Our investigations indicate that P-A PBS is more efficient than P-A NaCl mainly because RONS are produced in larger quantities. Indeed, we show that the cytotoxicity of these liquids directly correlates with the concentration of hydrogen peroxide and nitrite. Moreover, P-A PBS induced a faster-occurring and more pronounced cell death, which arose within deeper layers of the 3D multicellular spheroid models.

Entities:  

Keywords:  cancer; long-lived reactive oxygen and nitrogen species; multicellular tumor spheroids; plasma-activated liquids

Year:  2020        PMID: 32204401     DOI: 10.3390/cancers12030721

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  7 in total

Review 1.  Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions.

Authors:  Xavi Solé-Martí; Albert Espona-Noguera; Maria-Pau Ginebra; Cristina Canal
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

2.  Role of Short- and Long-Lived Reactive Species on the Selectivity and Anti-Cancer Action of Plasma Treatment In Vitro.

Authors:  Kyriakos Sklias; João Santos Sousa; Pierre-Marie Girard
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.639

3.  The Influence of Cold Atmospheric Pressure Plasma-Treated Media on the Cell Viability, Motility, and Induction of Apoptosis in Human Non-Metastatic (MCF7) and Metastatic (MDA-MB-231) Breast Cancer Cell Lines.

Authors:  Dominik Terefinko; Anna Dzimitrowicz; Aleksandra Bielawska-Pohl; Aleksandra Klimczak; Pawel Pohl; Piotr Jamroz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

4.  Plasma bioscience for medicine, agriculture and hygiene applications.

Authors:  Eun Ha Choi; Nagendra Kumar Kaushik; Young June Hong; Jun Sup Lim; Jin Sung Choi; Ihn Han
Journal:  J Korean Phys Soc       Date:  2022-03-04       Impact factor: 0.657

5.  Low-Temperature Plasma-Activated Medium Inhibited Proliferation and Progression of Lung Cancer by Targeting the PI3K/Akt and MAPK Pathways.

Authors:  Ying Li; Yang Lv; Yu Zhu; Xiaodong Yang; Boya Lin; Mengqing Li; Yaqi Zhou; Zhibo Tan; Eun Ha Choi; Junjie Wang; Shubin Wang; Yajie Liu
Journal:  Oxid Med Cell Longev       Date:  2022-03-18       Impact factor: 6.543

6.  Differential Effect of Non-Thermal Plasma RONS on Two Human Leukemic Cell Populations.

Authors:  Hager Mohamed; Eric Gebski; Rufranshell Reyes; Samuel Beane; Brian Wigdahl; Fred C Krebs; Katharina Stapelmann; Vandana Miller
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

7.  Plasma in Cancer Treatment.

Authors:  Angela Privat-Maldonado; Annemie Bogaerts
Journal:  Cancers (Basel)       Date:  2020-09-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.